We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
Cap. Flow
+$1.91B
Cap. Flow %
13.37%
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$139M
2
PG icon
Procter & Gamble
PG
+$118M
3
TFX icon
Teleflex
TFX
+$90.1M
4
MSFT icon
Microsoft
MSFT
+$89.4M
5
UBS icon
UBS Group
UBS
+$77.2M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$203M
2
AGN
Allergan plc
AGN
+$177M
3
MLNX
Mellanox Technologies, Ltd.
MLNX
+$118M
4
AMZN icon
Amazon
AMZN
+$115M
5
LIN icon
Linde
LIN
+$89.1M

Sector Composition

Rank Sector Weight
1 Healthcare 21.29%
2 Consumer Discretionary 15.87%
3 Technology 12.26%
4 Financials 12.01%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
1
Amazon
AMZN
$2.5T
$328M 2.3%
2,377,080
-953,140
-29% -$115M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$455B
$301M 2.11%
1,107,200
+994,200
+880% +$223M
ZTS icon
3
Zoetis
ZTS
$31.6B
$290M 2.03%
2,114,784
+404,604
+24% +$52.8M
BABA icon
4
Alibaba
BABA
$269B
$281M 1.97%
1,301,925
+287,286
+28% +$59.8M
TFX icon
5
Teleflex
TFX
$5.85B
$247M 1.73%
678,899
+260,910
+62% +$90.1M
TMO icon
6
Thermo Fisher Scientific
TMO
$211B
$209M 1.46%
576,678
-27,029
-4% -$9.06M
BHVN
7
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$183M 1.28%
2,501,444
-61,999
-2% -$3.3M
GLD icon
8
PUT
SPDR Gold Trust
GLD
$131B
$176M 1.23%
+982,300
New +$158M
MSFT icon
9
Microsoft
MSFT
$2.84T
$168M 1.18%
827,288
+492,637
+147% +$89.4M
FIS icon
10
Fidelity National Information Services
FIS
$21.5B
$156M 1.09%
1,161,877
-85,993
-7% -$11.3M
TMUS icon
11
T-Mobile US
TMUS
$193B
$156M 1.09%
1,494,376
+1,445,722
+2,971% +$139M
BSX icon
12
Boston Scientific
BSX
$65.8B
$149M 1.04%
4,240,928
+506,108
+14% +$18.2M
TRU icon
13
TransUnion
TRU
$14.8B
$148M 1.04%
1,704,367
+459,869
+37% +$36.7M
PG icon
14
Procter & Gamble
PG
$343B
$139M 0.97%
1,163,599
+1,009,353
+654% +$118M
A icon
15
Agilent Technologies
A
$39.1B
$139M 0.97%
1,570,149
-607,367
-28% -$49.8M
SPY icon
16
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$131M 0.92%
387,800
+386,300
+25,753% +$113M
IWM icon
17
CALL
iShares Russell 2000 ETF
IWM
$80.9B
$131M 0.92%
830,000
+521,200
+169% +$68.4M
ABBV icon
18
AbbVie
ABBV
$458B
$127M 0.89%
1,289,320
+704,319
+120% +$62M
GH icon
19
Guardant Health
GH
$19.5B
$123M 0.86%
1,518,082
+833,174
+122% +$67.1M
EPAM icon
20
EPAM Systems
EPAM
$4.69B
$114M 0.8%
452,993
+6,788
+2% +$1.49M
MNST icon
21
Monster Beverage
MNST
$91.4B
$109M 0.77%
3,150,530
+1,694,992
+116% +$55.3M
BIO icon
22
Bio-Rad Laboratories Class A
BIO
$8.42B
$105M 0.74%
233,102
+120,850
+108% +$53.3M
UBS icon
23
UBS Group
UBS
$170B
$104M 0.73%
9,076,437
+7,498,056
+475% +$77.2M
TLT icon
24
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$104M 0.73%
+628,700
New +$104M
HD icon
25
Home Depot
HD
$332B
$96.1M 0.67%
383,599
+174,689
+84% +$40M
1
2 3 4 5

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.

  • Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
  • Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
  • Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
  • Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
  • Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
  • Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
  • Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.

Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.